Uday Kompella
Founder en OCUGEN, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Uday B.
Kompella is a Director & Chief Scientific Officer, Independent Director, and Director at Ocugen, Inc. and Ocugen OpCo, Inc. respectively, both founded in 2013.
He is also a Professor-Pharmaceutical Sciences at CU Anschutz Medical Campus.
Dr. Kompella holds a doctorate from the University of Southern California, an undergraduate degree from Birla Institute of Technology & Science, and a graduate degree from Jadavpur University.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
OCUGEN INC
0.27% | 09/06/2023 | 705 090 ( 0.27% ) | 1 M $ | 31/03/2024 |
Cargos activos de Uday Kompella
| Empresas | Cargo | Inicio |
|---|---|---|
| OCUGEN, INC. | Founder | 01/01/2013 |
| Ocugen OpCo, Inc. | Founder | 01/09/2013 |
| CU Anschutz Medical Campus | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Uday Kompella.
| Empresas | Cargo | Fin |
|---|---|---|
Ocugen, Inc. /Old/
 Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Founder | - |
Formación de Uday Kompella.
| University of Southern California | Doctorate Degree |
| Birla Institute of Technology & Science | Undergraduate Degree |
| Jadavpur University | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| OCUGEN, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Ocugen, Inc. /Old/
Ocugen, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Ocugen, Inc. operates as a clinical stage biopharmaceutical firm. It discovers, develops, and commercializes therapies for rare and underserved eye diseases. The firm offers a robust and diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules. The company was founded by Shankar Musunuri and Uday Kompella in 2013 and is headquartered in Malvern, PA. | Health Technology |
| Ocugen OpCo, Inc. |
- Bolsa de valores
- Insiders
- Uday Kompella
